ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

Funding Opporunities: Program Announcments

January 15, 1999

Capitol Hill: Groups Warn Of Harm From Bill To Promote Breast Self-Exams

May 29, 2009